Results 101 to 110 of about 196,715 (351)
BACKGROUND: Lung cancer contributes significantly to cancer morbidity and mortality. Although case fatality rates have not changed significantly over the past few decades, there have been advances in the diagnosis, staging and management of lung cancer.
Sandor J Demeter +6 more
doaj +1 more source
Clinical and surgical-pathological staging in early non-small cell lung cancer
Staging is of the utmost importance in the evaluation of a patient with non-small cell lung cancer (NSCLC) because it defines the actual extent of the disease.
Ioannis Koukis +4 more
doaj +1 more source
New Horizons in Staging for Non–Small-Cell Lung Cancer [PDF]
Didier Lardinois
openalex +1 more source
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen +14 more
wiley +1 more source
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Enhancing TNM Stage Completeness Using the SEER Summary Stage: A Nationwide Study From Korea [PDF]
Objectives: Accurate and complete cancer staging is essential for effective prognosis and treatment planning. This study investigated the feasibility of enhancing the completeness of tumor‐node‐metastasis (TNM) staging by integrating Surveillance ...
Chang Kyun Choi +3 more
doaj +1 more source
A novel therapy for breast cancer: implications for treatment access [PDF]
In 2016, there were 250,000 new cases of invasive cancer and 60,000 of ductal carcinoma in situ. Mammograms are used to screen for cases of disease, but the literature shows that mammograms are highly dependent on patient characteristics and do not ...
Cespedes-Gomez, Omar
core
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Actualización de la estadificación del cáncer de pulmón Lung cancer staging: an update
The International Association for the Study of Lung Cancer (IASLC), junto con The International Union Against Cancer (UICC) y The American Joint Committee on Cancer (AJCC), crearon un Comité Internacional de Estadificación (ISC) que recopiló ...
Christian González +6 more
doaj
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis. [PDF]
Radiomics is an emerging technology for imaging biomarker discovery and disease-specific personalized treatment management. This paper aims to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization ...
Arasu, Vignesh A +13 more
core

